These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28256468)

  • 1. Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.
    Muthusamy K; Gopinath K; Nandhini D
    Indian J Med Res; 2016 Oct; 144(4):587-591. PubMed ID: 28256468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
    Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
    J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
    Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
    In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
    Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
    Front Immunol; 2019; 10():1424. PubMed ID: 31293584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.
    Mazumder R; Hu ZZ; Vinayaka CR; Sagripanti JL; Frost SD; Kosakovsky Pond SL; Wu CH
    Virus Genes; 2007 Oct; 35(2):175-86. PubMed ID: 17508277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
    Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
    PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine.
    Lim HX; Lim J; Poh CL
    Med Microbiol Immunol; 2021 Feb; 210(1):1-11. PubMed ID: 33515283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design.
    Hussain M; Idrees M; Afzal S
    Curr Comput Aided Drug Des; 2015; 11(1):84-97. PubMed ID: 26022067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1.
    Chen Y; Pan Y; Guo Y; Qiu L; Ding X; Che X
    Virology; 2010 Mar; 398(2):290-8. PubMed ID: 20079511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.
    Sabetian S; Nezafat N; Dorosti H; Zarei M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2546-2563. PubMed ID: 30035699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
    Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
    Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein.
    Tahir RA; Wu H; Rizwan MA; Jafar TH; Saleem S; Sehgal SA
    J Theor Biol; 2018 Dec; 459():162-170. PubMed ID: 30291844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity.
    Leng CH; Liu SJ; Tsai JP; Li YS; Chen MY; Liu HH; Lien SP; Yueh A; Hsiao KN; Lai LW; Liu FC; Chong P; Chen HW
    Microbes Infect; 2009 Feb; 11(2):288-95. PubMed ID: 19114121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super epitope dengue vaccine instigated serotype independent immune protection in-silico.
    Naskar S; Harsukhbhai Chandpa H; Agarwal S; Meena J
    Vaccine; 2024 Jul; 42(18):3857-3873. PubMed ID: 38616437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
    Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y
    Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
    Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
    BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.